Hospital Del Mar — Clinical Trial Site

474 Registered trials

203 Currently recruiting

Organisation

Hospital Del Mar

Location

Barcelona, Spain

Identifier

ORG-100028631

Address

Passeig Maritim De La Barceloneta 25-29, 08003, Spain

Departments

-
#034016 Oncología Médica
#2245; Nefrología
#2309:servicio de neurología
#2351: Servicio de dermatología
#2900; Cardiología
#3411 - Reumatología
#3456: Cardiología
#3850: Hematología
#6004:Oncología
#7004: Oncología Médica
#766; Oncología
#9102: Hematología Clínica
1101: Dermatología
1306: Hematologia y Transfusion
1307: Alliance Member
1400:Dermatología
2752; Dermatología
2802: Reumatología
34005: Oncología Médica
3411: Reumatología
3456: Servicio Dermatología
40890: Dermatologia
6500: Dermatología
7002:reumatología
7003: Oncología Médica
724007: Oncología Médica
9249: Servicio Dermatología
9751; Dermatología
Anaesthesiology
Anaesthesiology and Resucitation
Anestesiología y Reanimación
Anesthesiology
Anesthesiology, Resuscitation and Pain Therapy Department
Cap de Secció d´Hepatologia, Servei de Digestiu
Cardiology
cirugia
Clinic Hematology
Clinical Hematology
Critical Care Unit
Departamento de Neurología
Department of Infectious Diseases
Department of Urology
Dermathology unit
Dermatología
Dermatology
Dermatology department
Digestive service
Digestología
Endrocrinology
Farmacología Clínica
Gastroenterologia
Gastroenterology
Gastroenterology Unit
General and Digestive System Surgery
General Surgery
Ginecology and Obstetrics
Gynecological Department
Haematology
Heart Failure Unit
Hematología
Hematología Clínica
hematology
Hematology and Hemotherapy
Hematology department
Hepatology Section, Department of Gastroenterology
Hospital de día de infecciosas
Hospital del Mar
Hospital del Mar_Cardiología - Ensayos Clínicos
Hospital Pharmacy
IMIM-Hospital del Mar
Infecciosas
Infectious Disease Unit
Infectious Diseases
Infectious Diseases Department
Infectious Diseases Service
Integrative Pharmacology and Systems Neuroscience research group
Integrative Pharmacology and Systems Neurosciences
Intensive Care Unit
Medical Oncology
Medical Oncology Department
Medicina Interna /Enfermedades Infecciosas
Medicine
N/A
NA
Nefrología
Nefrología y Trasplante Renal
Nefrology
Nephrology
Nephrology and Kidney Transplant
Nephrology and Trasplant
Nephrology Department
Nephrology department, Pg. Marítim de la Barcelona, 25-29, Ciutat Vella, 08003 Barcelona, Spain
Nephrology Service
Neumología
Neumology
Neuro-Oncology
Neurology
Neurology department
Neurology Service
Nuclear Medicine
Obstetricia y Ginecología
Oftalmologia
Oncolgy
Oncologia
Oncología médica
ONCOLOGU
Oncology
Oncology department
Oncology Service
Otorhinolaryngolog Service
Otorhinolaryngology
Otorrinolaringología
Parc de Salut Mar - Hospital del Mar
Pharmacology
Pneumology
Pneumology service
Psiquiatría
Psychiatry
Pulmonology
Research Institute
Reumatología
Rheumatology
Servei de Dermatologia
Servei h'Hematologia Clinica
Servicio de digestivo
Servicio de Angiología y Cirugía vascular
Servicio de Cardiologia
Servicio de Dermatologia
Servicio de Digestología
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Hematologia Clinica
Servicio de Infecciosas
Servicio de Nefrologia
Servicio de Neumología
Servicio de Neurología
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatologia
Servicio de Urologia
Servico de Reumatologia
Thoracic Oncology
Treatment Resistant Schizophrenia and Psychosocial Rehabilitation Unit
Tuberculosis Unit, Service of Infectious Diseases
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de Cancer Genitourinaria
Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva.
Unidad de Insuficiencia Cardiaca
Unidad del Dolor
Unitat de deteriorament cognitiu i transtorns del moviment
URC
Urologia
Urology
Urology-Oncology
Vascular Surgery

Clinical trials at this site (474)

Search interface

Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting

2023-503335-18-00 Chronic myeloid leukemia 1 2022-07-29
Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the… Recruiting

2024-518242-24-00 Chronic liver disease 5 2022-06-27
Efficacy and safety of subcutaneous dupilumab for the treatment of adult participants with chronic pruritus of unknown origin (CPUO) Recruiting

2023-508879-36-00 Pruritus 5 2022-04-28
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituxim… Recruiting

2024-510690-16-00 Relapsed/refractory follicular lymphoma 5 2022-01-31
Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical tria… Recruiting

2023-509290-22-00 Severe Symptomatic Aortic Stenosis 6 2022-01-21
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting

2023-507372-42-00 Schizophrenia 4 2021-09-20
INTERCEPT Study Recruiting

2024-510615-29-00 Chronic active antibody-mediated rejection in kidney tr 5 2021-05-24
Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal… Recruiting

2024-514542-37-00 Select advanced solid tumors and Non-Small Cell Lung Ca 9 2020-08-13
A study to test different doses of obrixtamig (BI 764532) in patients with small cell lung cancer and other neuroendocrine tumours that are … Recruiting

2024-513100-34-00 Small Cell Lung Carcinoma and other neuroendocrine neop 1 2020-07-15
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting

2023-508302-24-00 Locally Advanced/Metastatic Urothelial Cancer 4 2019-05-07
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
A Study to Evaluate Efficacy and Safety of Multiple Treatment Combinations in Patients with Metastatic Breast Cancer (MORPHEUS-panBC) Recruiting

2023-503629-20-00 Metastatic breast cancer, including triple negative bre 9 2018-06-27
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
Autologous tolerogenic dendritic cells (ATDC) for highly sensitized kidney transplant recipients Ended

2024-519978-39-00 Kidney trasplants 3 2026-04-17
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
A study to determine if ALXN2030 is effective and safe in adults with antibody-mediated rejection after kidney transplantation (CONCORD) Ended

2024-517498-25-00 Antibody-Mediated Rejection after Kidney Transplantatio 4 2026-01-29
Comparison of continuing intravenous antibiotic therapy with switching to oral antibiotics in clinically stable patients with blood infectio… Ended

2024-517308-13-00 Gram-negative bacteraemia 6 2025-12-10
A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients with IgAN Ended

2025-521519-37-00 IgA Nephropathy (IgAN); Berger Disease; Renal and Urina 4 2025-10-10
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachmen… Ended

2025-520629-19-00 HIV Infections 3 2025-10-01
Study of BLU-808 in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria Ended

2024-520031-33-00 Chronic Inducible Urticaria and Chronic Spontaneous Urt 4 2025-09-16
A study on the safety, and immunogenicity of a UTI vaccine in adults 18 through 64 years of age and clinical efficacy in females 18 through … Ended

2024-519319-32-00 Urinary Tract Infections 7 2025-08-27
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31